Sukhatme Mayukh

SEC Form 4 insider

President & CIO · Roivant Sciences Ltd. ($ROIV)

2 theses · first seen Aug 19, 2026

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	1	1	0	0%	+0.1%	+0.1%
3d	1	1	1	100%	-2.9%	-2.9%
1w	0	0	0	—	—	—
1m	0	0	0	—	—	—
3m	0	0	0	—	—	—
6m	0	0	0	—	—	—
1y	0	0	0	—	—	—

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ROIVSEC Form 4bearish

Sukhatme Mayukh · President & CIO at Roivant Sciences Ltd. · 3h ago1 prior · awaiting results

Sold 335,174 @ $36.88 avg · $12,360,813 · 2026-08-19

Form 4: Sukhatme Mayukh sold ROIV

Sukhatme Mayukh (President & CIO at Roivant Sciences Ltd.) reported an open-market sale of 335,174 shares of ROIV at an average $36.88, roughly $12,360,813, in a Form 4 filed 2026-08-21.

At post $36.30Now $36.300.0% since postedas of Aug 21, 4:59 PM ET

View filing on SEC.gov →

$ROIVSEC Form 4bearish

Sukhatme Mayukh · President & CIO at Roivant Sciences Ltd. · 3d ago1 prior · awaiting results

Sold 664,826 @ $36.34 avg · $24,160,402 · 2026-08-14

Form 4: Sukhatme Mayukh sold ROIV

Sukhatme Mayukh (President & CIO at Roivant Sciences Ltd.) reported an open-market sale of 664,826 shares of ROIV at an average $36.34, roughly $24,160,402, in a Form 4 filed 2026-08-18.

At post $37.37Now $36.30-2.9% since postedas of Aug 21, 4:59 PM ET

1d+0.1%

3d-2.9%

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

End of results.